{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:53:44Z","timestamp":1761299624832,"version":"build-2065373602"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Project of Clinical Analysis of HIV\/AIDS Combined with Pulmonary Tuberculosis Co-Infection in Lianyungang City","award":["zd202006"],"award-info":[{"award-number":["zd202006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-025-00804-x","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:48:29Z","timestamp":1761299309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between cerebrospinal fluid CXCL10 and neurocognitive disorders in people living with HIV: a meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Qingqing","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"4","key":"804_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/coh.0000000000000951","volume":"20","author":"MM Diaz","year":"2025","unstructured":"Diaz MM. Update on neurological complications of HIV. Curr Opin HIV AIDS. 2025;20(4):337\u201343. https:\/\/doi.org\/10.1097\/coh.0000000000000951.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"804_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12981-024-00677-6","volume":"21","author":"T Olajide","year":"2024","unstructured":"Olajide T, Ogungbemi E, Olajide G, Ogundijo D, Osakuade O, Moshood F. HIV-associated neurocognitive disorders in Africa: challenges, peculiarities, and future directions. AIDS Res Ther. 2024;21(1):88. https:\/\/doi.org\/10.1186\/s12981-024-00677-6.","journal-title":"AIDS Res Ther"},{"key":"804_CR3","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2025-0004","author":"C Hou","year":"2025","unstructured":"Hou C, Wei J, Zhang H, Li H. Evolving strategies in the diagnosis and treatment of HIV-associated neurocognitive disorders. Rev Neurosci. 2025. https:\/\/doi.org\/10.1515\/revneuro-2025-0004.","journal-title":"Rev Neurosci"},{"issue":"7","key":"804_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1017\/s1041610221000156","volume":"35","author":"A Flatt","year":"2023","unstructured":"Flatt A, Gentry T, Kellett-Wright J, Eaton P, Joseph M, Urasa S, et al. Prevalence and 1-year incidence of HIV-associated neurocognitive disorder (HAND) in adults aged\u2009\u2265\u200950 years attending standard HIV clinical care in kilimanjaro, Tanzania. Int Psychogeriatr. 2023;35(7):339\u201350. https:\/\/doi.org\/10.1017\/s1041610221000156.","journal-title":"Int Psychogeriatr"},{"issue":"9\u201310","key":"804_CR5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1017\/s1355617717001102","volume":"23","author":"R Saloner","year":"2017","unstructured":"Saloner R, Cysique LA. HIV-Associated neurocognitive disorders: A global perspective. J Int Neuropsychol Soc. 2017;23(9\u201310):860\u20139. https:\/\/doi.org\/10.1017\/s1355617717001102.","journal-title":"J Int Neuropsychol Soc"},{"issue":"1","key":"804_CR6","doi-asserted-by":"publisher","first-page":"6470","DOI":"10.1038\/s41598-022-10474-8","volume":"12","author":"M Nweke","year":"2022","unstructured":"Nweke M, Mshunqane N, Govender N, Akinpelu AO, Ukwuoma M. Impact of HIV-associated cognitive impairment on functional independence, frailty and quality of life in the modern era: a meta-analysis. Sci Rep. 2022;12(1):6470. https:\/\/doi.org\/10.1038\/s41598-022-10474-8.","journal-title":"Sci Rep"},{"key":"804_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jpsychires.2016.10.016","volume":"85","author":"M Tsegaw","year":"2017","unstructured":"Tsegaw M, Andargie G, Alem G, Tareke M. Screening HIV-associated neurocognitive disorders (HAND) among HIV positive patients attending antiretroviral therapy in South wollo, Ethiopia. J Psychiatr Res. 2017;85:37\u201341. https:\/\/doi.org\/10.1016\/j.jpsychires.2016.10.016.","journal-title":"J Psychiatr Res"},{"issue":"5","key":"804_CR8","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s11481-013-9505-1","volume":"8","author":"S Cross","year":"2013","unstructured":"Cross S, \u00d6nen N, Gase A, Overton ET, Ances BM. Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale. J Neuroimmune Pharmacol. 2013;8(5):1114\u201322. https:\/\/doi.org\/10.1007\/s11481-013-9505-1.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"5","key":"804_CR9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/jnc.0000000000000036","volume":"30","author":"JK Namagga","year":"2019","unstructured":"Namagga JK, Rukundo GZ, Voss JG. Prevalence and risk factors of HIV-Associated neurocognitive disorders in rural Southwestern Uganda. J Assoc Nurses AIDS Care. 2019;30(5):531\u20138. https:\/\/doi.org\/10.1097\/jnc.0000000000000036.","journal-title":"J Assoc Nurses AIDS Care"},{"issue":"12","key":"804_CR10","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.11817\/j.issn.1672-7347.2024.230555","volume":"49","author":"Q Lu","year":"2024","unstructured":"Lu Q, Ye Q, Chen D, Li X. Neurocognitive function and its influencing factors in people living with HIV\/AIDS. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024;49(12):1902\u20138. https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2024.230555.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"3","key":"804_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/jnc.15295","volume":"157","author":"ME Williams","year":"2021","unstructured":"Williams ME, Naud\u00e9 PJW, van der Westhuizen FH. Proteomics and metabolomics of HIV-associated neurocognitive disorders: A systematic review. J Neurochem. 2021;157(3):429\u201349. https:\/\/doi.org\/10.1111\/jnc.15295.","journal-title":"J Neurochem"},{"key":"804_CR12","doi-asserted-by":"publisher","first-page":"117177","DOI":"10.1016\/j.biopha.2024.117177","volume":"178","author":"NK Bhol","year":"2024","unstructured":"Bhol NK, Bhanjadeo MM, Singh AK, Dash UC, Ojha RR, Majhi S, et al. The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds. Biomed Pharmacother. 2024;178:117177. https:\/\/doi.org\/10.1016\/j.biopha.2024.117177.","journal-title":"Biomed Pharmacother"},{"key":"804_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2025.05.003","author":"AA Bufi","year":"2025","unstructured":"Bufi AA, Di Stefano J, Papait A, Silini AR, Parolini O, Ponsaerts P. The central role of CXCL10-CXCR3 signaling in neuroinflammation and neuropathology. Cytokine Growth Factor Rev. 2025. https:\/\/doi.org\/10.1016\/j.cytogfr.2025.05.003.","journal-title":"Cytokine Growth Factor Rev"},{"key":"804_CR14","doi-asserted-by":"publisher","first-page":"134533","DOI":"10.1016\/j.neulet.2019.134533","volume":"715","author":"AES Watson","year":"2020","unstructured":"Watson AES, Goodkey K, Footz T, Voronova A. Regulation of CNS precursor function by neuronal chemokines. Neurosci Lett. 2020;715:134533. https:\/\/doi.org\/10.1016\/j.neulet.2019.134533.","journal-title":"Neurosci Lett"},{"key":"804_CR15","doi-asserted-by":"publisher","unstructured":"Elemam NM, Talaat IM, Maghazachi AA. CXCL10 chemokine: A critical player in RNA and DNA viral infections. Viruses. 2022;14(11). https:\/\/doi.org\/10.3390\/v14112445.","DOI":"10.3390\/v14112445"},{"issue":"1","key":"804_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5267","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8(1):267. https:\/\/doi.org\/10.1038\/s41392-023-01486-5267.","journal-title":"Signal Transduct Target Ther"},{"key":"804_CR17","doi-asserted-by":"publisher","unstructured":"Blandford SN, Fudge NJ, Moore CS. CXCL10 is associated with increased cerebrospinal fluid immune cell infiltration and disease duration in multiple sclerosis. Biomolecules. 2023;13(8). https:\/\/doi.org\/10.3390\/biom13081204.","DOI":"10.3390\/biom13081204"},{"key":"804_CR18","doi-asserted-by":"publisher","unstructured":"Da Silva SJ, Cabral-Castro MJ, Faria LC, Rosadas C, de Ara\u00fajo MFL, Dutra ACS, et al. CXCL-10 in cerebrospinal fluid detects neuroinflammation in HTLV-1-Associated myelopathy with high accuracy. Viruses. 2025;17(1). https:\/\/doi.org\/10.3390\/v17010089.","DOI":"10.3390\/v17010089"},{"issue":"1","key":"804_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13195-023-01254-1","volume":"15","author":"F Zhou","year":"2023","unstructured":"Zhou F, Sun Y, Xie X, Zhao Y. Blood and CSF chemokines in alzheimer\u2019s disease and mild cognitive impairment: a systematic review and meta-analysis. Alzheimers Res Ther. 2023;15(1):107. https:\/\/doi.org\/10.1186\/s13195-023-01254-1.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"804_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9(1):42. https:\/\/doi.org\/10.1186\/s40035-020-00221-2.","journal-title":"Transl Neurodegener"},{"issue":"6","key":"804_CR21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.17219\/acem\/68846","volume":"27","author":"OM Koper","year":"2018","unstructured":"Koper OM, Kami\u0144ska J, Sawicki K, Kemona H. CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration. Adv Clin Exp Med. 2018;27(6):849\u201356. https:\/\/doi.org\/10.17219\/acem\/68846.","journal-title":"Adv Clin Exp Med"},{"key":"804_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cyto.2018.11.018","volume":"115","author":"J Lei","year":"2019","unstructured":"Lei J, Yin X, Shang H, Jiang Y. IP-10 is highly involved in HIV infection. Cytokine. 2019;115:97\u2013103. https:\/\/doi.org\/10.1016\/j.cyto.2018.11.018.","journal-title":"Cytokine"},{"key":"804_CR23","doi-asserted-by":"publisher","first-page":"1447926","DOI":"10.3389\/fimmu.2024.1447926","volume":"15","author":"M Mej\u00edas-Trueba","year":"2024","unstructured":"Mej\u00edas-Trueba M, Saborido-Alconchel A, Serna-Gallego A, Trujillo-Rodr\u00edguez M, Mu\u00f1oz-Muela E, Llaves-Flores S, et al. Plasma concentrations of IL-6, MIP-1\u03b2, IP-10, and PTX-3 as predictors of the immunological response to antiretroviral treatment in people with HIV. Front Immunol. 2024;15:1447926. https:\/\/doi.org\/10.3389\/fimmu.2024.1447926.","journal-title":"Front Immunol"},{"key":"804_CR24","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"804_CR25","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. https:\/\/doi.org\/10.1136\/bmj.n160.","journal-title":"BMJ"},{"key":"804_CR26","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.2. The Cochrane Collaboration. 2021;www.training.cochrane.org\/handbook"},{"key":"804_CR27","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2010;http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"issue":"11","key":"804_CR28","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358. https:\/\/doi.org\/10.1002\/sim.1186.","journal-title":"Stat Med"},{"issue":"4","key":"804_CR29","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ajodo.2019.12.011","volume":"157","author":"LM Spineli","year":"2020","unstructured":"Spineli LM, Pandis N. Prediction interval in random-effects meta-analysis. Am J Orthod Dentofac Orthop. 2020;157(4):586\u20138. https:\/\/doi.org\/10.1016\/j.ajodo.2019.12.011.","journal-title":"Am J Orthod Dentofac Orthop"},{"issue":"7109","key":"804_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"key":"804_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/1742-2094-9-239","volume":"9","author":"R Mehla","year":"2012","unstructured":"Mehla R, Bivalkar-Mehla S, Nagarkatti M, Chauhan A. Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator. J Neuroinflammation. 2012;9:239. https:\/\/doi.org\/10.1186\/1742-2094-9-239.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"804_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s13365-013-0150-5","volume":"19","author":"L Yuan","year":"2013","unstructured":"Yuan L, Qiao L, Wei F, Yin J, Liu L, Ji Y, et al. Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China. J Neurovirol. 2013;19(2):144\u20139. https:\/\/doi.org\/10.1007\/s13365-013-0150-5.","journal-title":"J Neurovirol"},{"issue":"2","key":"804_CR33","doi-asserted-by":"publisher","first-page":"e0116526","DOI":"10.1371\/journal.pone.0116526","volume":"10","author":"RD Schrier","year":"2015","unstructured":"Schrier RD, Hong S, Crescini M, Ellis R, P\u00e9rez-Santiago J, Spina C, et al. Cerebrospinal fluid (CSF) CD8\u2009+\u2009T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND). PLoS ONE. 2015;10(2):e0116526. https:\/\/doi.org\/10.1371\/journal.pone.0116526.","journal-title":"PLoS ONE"},{"key":"804_CR34","doi-asserted-by":"publisher","first-page":"506872","DOI":"10.1155\/2015\/506872","volume":"2015","author":"L Yuan","year":"2015","unstructured":"Yuan L, Liu A, Qiao L, Sheng B, Xu M, Li W, et al. The relationship of CSF and plasma cytokine levels in HIV infected patients with neurocognitive impairment. Biomed Res Int. 2015;2015:506872. https:\/\/doi.org\/10.1155\/2015\/506872.","journal-title":"Biomed Res Int"},{"key":"804_CR35","doi-asserted-by":"publisher","unstructured":"Kallianpur AR, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan JS, Bush WS,et al. Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.Mol Neurobiol. 2019;56(5):3808-18. https:\/\/doi.org\/10.1007\/s12035-018-1329-9","DOI":"10.1007\/s12035-018-1329-9"},{"key":"804_CR36","doi-asserted-by":"publisher","unstructured":"Ozturk T, Kollhoff A, Anderson AM, Christina Howell J, Loring DW, Waldrop-Valverde D, et al. Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder. Sci Rep. 2019;9(1):8733. https:\/\/doi.org\/10.1038\/s41598-019-45418-2 8733","DOI":"10.1038\/s41598-019-45418-2"},{"key":"804_CR37","doi-asserted-by":"publisher","unstructured":"Burlacu R, Umlauf A, Marcotte TD, Soontornniyomkij B, Diaconu CC, Bulacu-Talnariu A, et al. Plasma CXCL10 correlates with HAND in HIV-infected women. J Neurovirol.2020;26(1):23\u201331. https:\/\/doi.org\/10.1007\/s13365-019-00785-4","DOI":"10.1007\/s13365-019-00785-4"},{"key":"804_CR38","doi-asserted-by":"publisher","unstructured":"De Almeida SM, Rotta I, Tang B, Umlauf A, Vaida F, Cherner M, et al. Higher Cerebrospinal Fluid Soluble Urokinase-type Plasminogen Activator Receptor, But Not Interferon \u03b3-inducible Protein 10, Correlate With Higher Working Memory Deficits. J Acquir Immune Defic Syndr. 2022;90(1):106\u2009\u2013\u200914. dhttps:\/\/doi.org\/10.1097\/qai.0000000000002924.","DOI":"10.1097\/qai.0000000000002924."},{"key":"804_CR39","doi-asserted-by":"publisher","unstructured":"Guha D, Misra V, Yin J, Horiguchi M, Uno H, Gabuzda D. Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy. AIDS. 2023;37(14):2137-47. https:\/\/doi.org\/10.1097\/QAD.0000000000003675.","DOI":"10.1097\/QAD.0000000000003675."},{"key":"804_CR40","doi-asserted-by":"publisher","unstructured":"Hu Z, Cinque P, Dravid A, Hagberg L, Yilmaz A, Zetterberg H, et al. Changes in cerebrospinal fluid proteins across the spectrum of untreated and treated chronic HIV-1 infection. PLoS Pathog. 2024;20(9):e1012470. https:\/\/doi.org\/10.1371\/journal.ppat.1012470.","DOI":"10.1371\/journal.ppat.1012470."},{"key":"804_CR41","doi-asserted-by":"publisher","unstructured":"Diaz MM, Kamalyan L, Al-Rousan T, Breton J, Franklin DR, Jr., Umlauf A, et al.Cerebrospinal fluid biomarkers of inflammation and immune activation associated with neurocognitive impairment among US Latinos with HIV. AIDS. 2025;39(7):838\u2009\u2013\u200947. https:\/\/doi.org\/10.1097\/qad.0000000000004143.","DOI":"10.1097\/qad.0000000000004143."},{"key":"804_CR42","doi-asserted-by":"publisher","unstructured":"Liu M, Guo S, Hibbert JM, Jain V, Singh N, Wilson NO, et al. CXCL10\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 2011;22(3):121\u2009\u2013\u200930. https:\/\/doi.org\/10.1016\/j.cytogfr.2011.06.001.","DOI":"10.1016\/j.cytogfr.2011.06.001."},{"key":"804_CR43","doi-asserted-by":"publisher","unstructured":"Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta. 2014;1843(11):2563-82. https:\/\/doi.org\/10.1016\/j.bbamcr.2014.05.014.","DOI":"10.1016\/j.bbamcr.2014.05.014."},{"key":"804_CR44","doi-asserted-by":"publisher","unstructured":"Yin X, Wang Z, Wu T, Ma M, Zhang Z, Chu Z, et al. The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression. J Transl Med. 2019;17(1):417. https:\/\/doi.org\/10.1186\/s12967-019-02172-3.","DOI":"10.1186\/s12967-019-02172-3."},{"key":"804_CR45","doi-asserted-by":"publisher","unstructured":"Anderson AM, Kundu S, Tang B, Vaida F, Okwuegbuna O, McClernon D, et al. Cerebrospinal fluid CXCL10 is associated with the presence of low level CSF HIV during suppressive antiretroviral therapy. J Neuroimmunol. 2021;353:577493. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577493.","DOI":"10.1016\/j.jneuroim.2021.577493."},{"key":"804_CR46","doi-asserted-by":"publisher","unstructured":"Valverde-Villegas JM, de Medeiros RM, Ellwanger JH, Santos BR, Melo MG, Almeida SEM, et al. High CXCL10\/IP-10 levels are a hallmark in the clinical evolution of the HIV infection. Infect Genet Evol. 2018;57:51\u2009\u2013\u20098. https:\/\/doi.org\/10.1016\/j.meegid.2017.11.002.","DOI":"10.1016\/j.meegid.2017.11.002."},{"key":"804_CR47","doi-asserted-by":"publisher","unstructured":"Sui Y, Potula R, Dhillon N, Pinson D, Li S, Nath A, et al. Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis.Am J Pathol. 2004;164(5):1557-66. https:\/\/doi.org\/10.1016\/s0002-9440(10)63714-5.","DOI":"10.1016\/s0002-9440(10)63714-5."},{"key":"804_CR48","doi-asserted-by":"publisher","unstructured":"Cho J, Nelson TE, Bajova H, Gruol DL. Chronic CXCL10 alters neuronal properties in rat hippocampal culture. J Neuroimmunol. 2009;207(1\u20132):92\u2013100. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.12.007.","DOI":"10.1016\/j.jneuroim.2008.12.007."},{"key":"804_CR49","doi-asserted-by":"publisher","unstructured":"Tousi NS, Buck DJ, Curtis JT, Davis RL. \u03b1-Synuclein potentiates interleukin-1\u03b2-induced CXCL10 expression in human A172 astrocytoma cells. Neurosci Lett. 2012;507(2):133-6. https:\/\/doi.org\/10.1016\/j.neulet.2011.12.001.","DOI":"10.1016\/j.neulet.2011.12.001."},{"key":"804_CR50","doi-asserted-by":"publisher","unstructured":"Lawrence JM, Schardien K, Wigdahl B, Nonnemacher MR. Roles of neuropathology-associated reactive astrocytes: a systematic review. Acta Neuropathol Commun. 2023;11(1):42. https:\/\/doi.org\/10.1186\/s40478-023-01526-9.","DOI":"10.1186\/s40478-023-01526-9."},{"key":"804_CR51","doi-asserted-by":"publisher","unstructured":"Bandera A, Taramasso L, Bozzi G, Muscatello A, Robinson JA, Burdo TH, et al. HIV-Associated Neurocognitive Impairment in the Modern ART Era: Are We Close to Discovering Reliable Biomarkers in the Setting of Virological Suppression? Front Aging Neurosci. 2019;11:187. https:\/\/doi.org\/10.3389\/fnagi.2019.00187.","DOI":"10.3389\/fnagi.2019.00187."},{"key":"804_CR52","doi-asserted-by":"publisher","unstructured":"Hong S, Banks WA. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications. Brain Behav Immun. 2015;45:1\u201312. https:\/\/doi.org\/10.1016\/j.bbi.2014.10.008.","DOI":"10.1016\/j.bbi.2014.10.008."},{"key":"804_CR53","doi-asserted-by":"publisher","unstructured":"Carey CL, Woods SP, Rippeth JD, Gonzalez R, Moore DJ, Marcotte TD, et al. Initial validation of a screening battery for the detection of HIV-associated cognitive impairment.Clin Neuropsychol. 2004;18(2):234\u2009\u2013\u200948. https:\/\/doi.org\/10.1080\/13854040490501448.","DOI":"10.1080\/13854040490501448."},{"key":"804_CR54","doi-asserted-by":"publisher","unstructured":"Blackstone K, Moore DJ, Franklin DR, Clifford DB, Collier AC, Marra CM, et al.Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings.Clin Neuropsychol. 2012;26(6):894\u2013908. https:\/\/doi.org\/10.1080\/13854046.2012.694479.","DOI":"10.1080\/13854046.2012.694479."},{"key":"804_CR55","doi-asserted-by":"publisher","unstructured":"Kompella S, Al-Khateeb T, Riaz OA, Orimaye SO, Sodeke PO, Awujoola AO, et al.HIV-Associated Neurocognitive Disorder (HAND): Relative Risk Factors. Curr Top Behav Neurosci. 2021;50:401\u2009\u2013\u200926. https:\/\/doi.org\/10.1007\/7854_2020_131.","DOI":"10.1007\/7854_2020_131."},{"key":"804_CR56","doi-asserted-by":"publisher","unstructured":"Adhikary K, Banerjee A, Sarkar R, Banerjee R, Chowdhury SR, Ganguly K, et al.HIV-associated neurocognitive disorders (HAND): Optimal diagnosis, antiviral therapy,pharmacological treatment, management, and future scopes. J Neurol Sci. 2025;470:123410. https:\/\/doi.org\/10.1016\/j.jns.2025.123410.","DOI":"10.1016\/j.jns.2025.123410."}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-025-00804-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:48:32Z","timestamp":1761299312000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00804-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["804"],"URL":"https:\/\/doi.org\/10.1186\/s12981-025-00804-x","relation":{},"ISSN":["1742-6405"],"issn-type":[{"type":"electronic","value":"1742-6405"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board approval was not required because this is a meta-analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}